Rheumatologe

Blog von Dr. med. Lothar M. Kirsch / 祁建德 // Poetry / Travels / Languages / Rheumatic Diseases / Tea

Seiten / Pages

▼
Showing posts with label Guselkumab. Show all posts
Showing posts with label Guselkumab. Show all posts
Monday, September 24, 2018

WIN-Session SpA/PsA beim Kongress der DGRh 2018 in Mannheim

›
Bei der WIN-Session SpA/PsA beim Kongress der DGRh 2018 in Mannheim ( WIN steht für What is new?) kamen doch einige neue Erkennt...
Thursday, March 8, 2018

Guselkumab at the 2017 ACR Annual Meeting in San Diego

›
Guselkumab is a monoclonal antibody that targets the p19 subunit of IL-23. Guselkumab is marketed by Janssen-Cilag under the name...
Friday, June 16, 2017

Guselkumab at the 2017 EULAR Annual Meeting in Madrid

›
You might never have heard about guselkumab, which targets IL-23. Other MABs targeting IL-23 include briakinumab (nothing at the ...
Wednesday, December 21, 2016

What’s in the names of drugs in rheumatology?

›
As soon as I see drug names, I associate something. What’s in the names of drugs in rheumatology? I’ll show you some associations. Maybe ...
1 comment:
›
Home
View web version

Über mich / About myself / 自己的介绍

Rheumatologe
View my complete profile
Powered by Blogger.